TB-500 Fragment

TB-500 Fragment

The isolated LKKTETQ core fragment of Thymosin Beta-4, delivering the primary actin-sequestration activity in a smaller, more focused peptide sequence.

RecoveryImmune
● In Stock

Buy more, save more

1+ vials
−5%
3+ vials
−10%
5+ vials
−20%
10+ vials

Total Price

$40

For research & laboratory use only. Not for human consumption.

Half-Life

~4-6 hours

Administration Route

Subcutaneous injection

Tendon-Specific Action

TB-500 C-terminal fragment with concentrated joint repair

Lower Systemic Dose

Localised effect profile; reduced systemic TB-500 dosing

Synergistic with BPC-157

Complements BPC-157 for complete musculoskeletal repair

Effect Profile

Tissue Healing

0%

Anti-Inflammatory

0%

Pain Relief

0%

Mobility Restoration

0%

Mechanism of Action

TB-500 Fragment is the heptapeptide LKKTETQ (amino acids 17-23 of Thymosin Beta-4), which constitutes the minimum active sequence for G-actin binding. By sequestering free actin monomers, it modulates the dynamic equilibrium between globular (G) and filamentous (F) actin, enhancing cell motility, angiogenesis, and migration of repair cells to sites of injury.

Scientific Research

Product FAQs

Stacks Well With

Related Products

Cart

Your cart is empty